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Abstract
Albeit previous experiments suggest potential anti- inflammatory effect of exog-
enous methane (CH4) in various organs, the mechanism of its bioactivity is not en-
tirely understood. We aimed to investigate the potential mitochondrial effects and 
the underlying mechanisms of CH4 in rat cardiomyocytes and mitochondria under 
simulated ischaemia/reperfusion (sI/R) conditions. Three- day- old cultured cardiomy-
ocytes were treated with 2.2% CH4- artificial air mixture during 2- hour- long reoxy-
genation following 4- hour- long anoxia (sI/R and sI/R + CH4, n = 6- 6), with normoxic 
groups serving as controls (SH and SH + CH4; n = 6- 6). Mitochondrial functions were 
investigated with high- resolution respirometry, and mitochondrial membrane injury 
was detected by cytochrome c release and apoptotic characteristics by using TUNEL 
staining. CH4 admixture had no effect on complex II (CII)- linked respiration under 
normoxia but significantly decreased the complex I (CI)- linked oxygen consumption. 
Nevertheless, addition of CH4 in the sI/R + CH4 group significantly reduced the 
respiratory activity of CII in contrast to CI and the CH4 treatment diminished mito-
chondrial H2O2 production. Substrate- induced changes to membrane potential were 
partially preserved by CH4, and additionally, cytochrome c release and apoptosis of 
cardiomyocytes were reduced in the CH4- treated group. In conclusion, the addition 
of CH4 decreases mitochondrial ROS generation via blockade of electron transport 
at CI and reduces anoxia- reoxygenation- induced mitochondrial dysfunction and car-
diomyocyte injury in vitro.
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1  | INTRODUC TION
Ischaemic heart disease is a leading cause of death worldwide. The 
underlying pathophysiology is multifactorial, but mitochondrial dys-
function, is thought to be the common denominator in ischaemia 
or ischaemia/reperfusion (I/R)- mediated cardiomyocyte- damaging 
events.1,2
Methane (CH4) forms part of the gaseous environment, which 
maintains the metabolism within living aerobic cells. Though it is con-
sidered to be biologically inert, several studies have demonstrated 
bioactivity for exogenous CH4 in animal models of ischaemia and 
inflammation,3– 5 and accumulating experimental data suggest that 
exogenous CH4 can influence mammalian energy homeostasis as 
well.3– 6 More importantly, the administration of CH4 has improved 
cardiac function, reduced the level of necroenzymes and prevented 
myocardial fibrosis and remodelling in acute and chronic rodent 
models of myocardial infarction.4 Whereas these results suggest a 
causal link between increased CH4 input and the hypoxia- induced 
oxido- reductive stress response, the subcellular mechanisms of ac-
tion are still unclear.
The major goal of this study was to outline a mitochondrial 
pathway, which explains the bioactivity of CH4. In designing our 
experiments, we took into account that CH4 can easily traverse 
cell membranes and that the molecules move down their concen-
tration gradient into subcellular compartments.7 Further, previ-
ous findings have demonstrated that CH4 treatment can preserve 
adenosine- triphosphate (ATP) production after I/R injuries to 
the liver and eyes.5,6 Therefore, these results strengthened the 
view that the mitochondrion is among the expected intracellular 
targets of CH4 and led us to hypothesize that increased exoge-
nous CH4 input can influence the respiratory activity of cardiac 
mitochondria.8
Against this background, we carried out a sequential explora-
tion of the mitochondrial effects of exogenous CH4 in normoxic 
and simulated I/R environments using a high- resolution respirom-
etry (HRR) system to quantify the electron transport chain (ETC) 
responses. Ischaemia can impair the mitochondrial respiration and 
other oxygen- dependent cellular functions, leading to reversible or 
irreversible structural damage; therefore, we also detected cell via-
bility and apoptosis of cardiomyocytes as final outcomes.
2  | MATERIAL S AND METHODS
2.1 | Photoacoustic spectroscopy (PAS) 
measurement of CH4 concentration
The dynamics of the CH4 concentration changes were detected by 
photoacoustic spectroscopy (PAS), as described previously.9 Briefly, 
PAS is a special mode of spectroscopy, which measures optical 
absorption indirectly via the conversion of absorbed light energy 
into acoustic waves. The set- up allows for online measurements of 
CH4 concentrations with a minimum detectable concentration of 
0.25 ppm. The CH4 concentration in the medium was measured over 
a period of 120 min, and samples were taken every 2 min.
2.2 | Cardiomyocyte cell culture
Neonatal rat cardiac myocytes (NRMCs) were isolated, as described 
previously.10 Briefly, 1- 3- day- old Wistar rats were sacrificed by cervi-
cal dislocation, and the hearts were excised and collected in ice- cold 
phosphate- buffered saline. After the atria were removed, the ventri-
cles were minced with scissors and digested with 0.25% trypsin for 
25 min. The cell suspension was centrifuged at 2000 rpm for 15 min 
at 4°C. Pelleted cells were pre- plated for 90 min at 37°C to sepa-
rate the cardiac myocyte- enriched fraction. Cardiac myocytes were 
collected and counted in a Burker chamber and plated into 24- well 
plates (7 × 104 cells/well) and into 75 cm2 flasks (4 × 106 cells/flask). 
Cells were harvested in Dulbecco's Modified Eagle's growth medium 
(DMEM) supplemented with a 10% foetal bovine serum (FBS), 1% 
glutamine and 1% antibiotic/antimycotic solution for 24 hours, and 
then, the medium was changed to 1% FBS- containing growth me-
dium to promote the differentiation of the cardiomyocytes. At the 
end of the three- day isolation protocol, the phenotype of NRMCs 
corresponds to that of cardiomyocytes isolated from adult rats. The 
cardiac myocytes were kept in a normoxic incubator to maintain 
physiological conditions (37°C, 5% CO2 and 95% air).
2.3 | Isolation of cardiac mitochondria
Adult Sprague Dawley rats were anaesthetized with sodium pento-
barbital (45 mg/kg ip) to harvest the heart. The hearts were homog-
enized with a glass Potter homogenizer, and the mitochondria were 
isolated with Gnaiger's method.11 The isolated mitochondria were 
suspended in a 2.5 mL mitochondrial respiration medium (MiRo5) 
for respirometric analysis and were treated as follows: 2 hours nor-
moxia (95% air and 5%CO2) or anoxia (100%N2) was followed by re-
oxygenation (with or without CH4) for 30 minutes. At the end of the 
experiments, mitochondrial function was tested.
2.4 | Experimental protocols
The experiments were performed in two series using either intact 
NRMCs (Study I) or isolated cardiac mitochondria (Study II). In the 
first series, three- day- old cardiac myocytes were subjected to 
4 hours simulated ischaemia (sI). The cells were kept in a hypoxic 
chamber (37°C, 95% N2 and 5% CO2), and the culture medium was 
changed to a hypoxic solution (in mM: NaCl 119, KCl 5.4, MgSO4 
1.3, NaH2PO4 1.2, 4- (2- hydroxyethyl)- 1- piperazineethanesulfo
nic acid (HEPES) 5, MgCl2 0.5, CaCl2 0.9, Na lactate 20; bovine 
serum albumin (BSA) 0.1%, 310 mOsm/L, pH = 6.4). This was fol-
lowed by a 2h- reoxygenation period (R) in a culture medium when 
cells were kept under either normoxic conditions (37°C, artificial 
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air) or in a chamber with normoxic air supplemented with CH4 
(37°C, 2.2% CH4 + artificial air) (the sI/R and sI/R + CH4 groups, 
respectively). Control groups were kept in a normoxic incubator 
to maintain physiological conditions for 4 hours (normoxic solu-
tion containing 125 mmol/L NaCl, 5.4 mmol/L KCl, 1.3 mmol/L 
MgSO4, 1.2 mmol/L NaH2PO4, 20 mmol/L HEPES, 0.5 mmol/L 
MgCl2, 1 mmol/L CaCl2, 15 mmol/L glucose, 5 mmol/L taurine, 
2.5 mmol/L creatine- monohydrate and 0.1% BSA at pH 7.4), which 
was followed by a 2h- reoxygenation period in the normoxic in-
cubator with or without CH4 supplementation (the normoxia and 
normoxia + CH4 groups). Isolation rounds from the same litters of 
newborn rats (8- 16 hearts) were performed for each experimen-
tal group resulting in 2- 4 flasks of NRMCs (4 × 106 cells/flask) 
per isolation (n = 6- 6 per group). Data for all individual wells were 
analysed. At the end of the isolation protocol, the NRMCs were 
subjected to HRR and cell viability assays (Figure S1).
In the second series, isolated cardiac mitochondria were 
treated as follows: anoxia was induced using 100% N2 persuffla-
tion for 2 hours into a 2 mL volume cuvette containing 1 mL re-
spiratory medium and 1 mL airspace. Anoxia was followed by a 
reoxygenation period (95% air and 5% CO2) with or without 2.2% 
CH4 supplementation for 30 minutes (the A/R and A/R + CH4 
groups, respectively) (n = 12- 16). In the control groups, the mi-
tochondria were kept in normoxic cuvettes (95% air and 5% CO2) 
with or without 2.2% CH4 supplementation (the normoxia and 
normoxia + CH4 groups, respectively). Then, the mitochondria 
were subjected to HRR (Figure S2).
2.5 | Examination of mitochondrial functions
High- resolution respirometry with an Oxygraph- 2k (Oroboros 
Instruments, Innsbruck, Austria) was used to examine the oxygen 
consumption of the NRMCs and isolated cardiac mitochondria in 
various mitochondrial metabolic states, mitochondrial hydrogen per-
oxide (H2O2) production and changes to mitochondrial membrane 
potential. The mitochondrial protein content of the samples was de-
termined by Lowry's method.
2.6 | Coupling control protocol
Before the mitochondrial metabolic states were examined, a cell per-
meabilization protocol of the NRMCs was applied in the respirom-
eter chamber (Figure S3).
Next, we applied a coupling control protocol to the permeabi-
lized NRMCs. First, endogenous routine respiration was defined 
without substrates. Then, the cells were permeabilized with digi-
tonin, and the oxidative phosphorylation capacity (OxPhos, State 3) 
of the NRMCs was measured by adding 10 mmol/L succinate (Succ) 
and 5 mmol/L ADP substrates. Subsequently, ATP- independent res-
piration was measured using 0.5 µmol/L oligomycin (Omy). Maximal 
mitochondrial respiratory capacity was then measured by titration 
of 1 µmol/L carbonyl cyanide p- trifluoromethoxy- phenyl- hydrazine 
(FCCP). Finally, residual oxygen consumption (ROX) was determined 
by adding 1 μmol/L rotenone (Rot) and 1 μmol/L antimycin- A (Ama).
2.7 | Mitochondrial hydrogen peroxide 
(H2O2) production
In this series, mitochondrial H2O2 release as a marker of reactive 
oxygen species (ROS) (ie superoxide anion) production was moni-
tored fluorimetrically with the Amplex Red/horseradish peroxidase 
system, whereby Amplex Red (non- fluorescent) is oxidized to re-
sorufin. H2O2 production was calibrated with known amounts of 
H2O2. In this setup, ROS release was investigated by adding oxidiz-
ing substrates (20 mmol/L glutamate, 10 mmol/L malate, 10 mmol/L 
succinate, 5 mmol/L ADP) to the mitochondria. On isolated mito-
chondria, the reverse electron transport (RET)- initiated H2O2 flux 
was measured when mitochondria were incubated with 10 mmol/L 
succinate; it was then blocked by the addition of 1 µmol/L rotenone. 
The residual oxygen consumption was estimated after addition of 
1 μmol/L antimycin- A (inhibitor of CIII) to exclude the effects of oxi-
dative side reactions. Then, free radical leak was also determined as 
the percentage of oxygen consumption diverted to the production 
of H2O2 in State 3.
2.8 | Mitochondrial membrane potential
Mitochondrial membrane potential was measured fluorimetri-
cally using the fluorophore safranin. First, we added 1 µmol/L Rot, 
10 mmol/L succinate and 1 µmol/L FCCP. Finally, ROX was deter-
mined by adding 1 μmol/L antimycin- A (Ama). Extramitochondrial 
Ca2+ movement (as it indicates strong correlation with membrane 
potential12) was examined with the use of blue fluorescence sensor 
of HRR (excitation 465 nm; gain for sensor: 1000 and polarization 
voltage: 500 mV) (Figure S4).
2.9 | Detection of cytochrome c oxidase activity
Cytochrome c oxidase activity was calculated via the time- dependent 
oxidation of cytochrome c at 550 nm, as described previously. 
Briefly, a cytochrome c stock solution was freshly prepared by dis-
solving 10.6 mg cytochrome c (Sigma- Aldrich, Budapest, Hungary) in 
20 mL distilled water. The cytochrome c was then reduced by adding 
50 µL 0.1 mol/L sodium dithionite, with the absorbance of the solu-
tion determined at 550 nm; the photometer was calibrated to this 
level. Heart samples were homogenized with a Potter grinder in 10× 
ice- cold Miro5 medium and then centrifuged at 800 g for 5 minutes 
at 4°C. 50 μL supernatant was added to 2.5 mL cytochrome c stock 
solution, and the decrease in optical density at 550 nm was meas-
ured spectrophotometrically during 1 minute intervals at 0, 30 and 
60 minutes.
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2.10 | TUNEL and DAPI staining
Apoptosis of the NRMCs was detected with the TUNEL method. First, 
the cell number was detected, and then, a cytocentrifuge (6 minutes, 
600 rpm, 50 000 cells/slide) was used to create cytospin samples. 
Samples (n = 6 each) were analysed for apoptotic cell staining with In 
Situ Cell Death Detection Kit TMR red (Roche, Cat. No. 12 156 792 910). 
The cytospin samples were fixed in 4% paraformaldehyde for 60 min-
utes and then permeabilized on ice for 2 minutes in 0.1% Triton X- 100 in 
0.1% sodium citrate. We used one part enzyme solution and nine parts 
label solution for the TUNEL reaction mixture according to the manu-
facturer's instructions. The cytospin samples were incubated in the dark 
for 60 minutes at 37°C in a humidified atmosphere, followed by DAPI 
staining (Sigma- Aldrich, Cat. No. 10236276001). For each experimental 
series, one negative control (incubated only with the label solution) and 
one positive control (digested with DNase I (Quiagen, Cat. No. 79254) 
together with the TUNEL reaction mixture), and three normal (only with 
the TUNEL mixture) samples were used. Three pictures were taken of 
each sample (negative control, positive control and three normal samples 
each) in each experimental series with a Zeiss AxioImager.Z1 microscope 
at 20× magnification. The number of apoptotic cells per field of view 
(524.19 μm × 524.19 μm) was determined with Image J 1.47 software.
2.11 | Cell viability assay and lactate dehydrogenase 
(LDH) release
The NRMCs were incubated with 1 μmol/L calcein acetoxymethyl 
ester (Sigma- Aldrich, Cat. No. 56496 calcein- AM, Sigma, St. Louis, MO) 
dissolved in dimethyl sulfoxide at room temperature for 30 minutes 
to assess cell viability. Fluorescence intensity was measured with a 
fluorescence plate reader (Fluostar Optima, BMG Labtech, Ortenberg, 
Germany). Cell viability was compared with that of vehicle control. 
Cytotoxicity was also measured with the level of LDH released from the 
damaged cells into the medium culture with the available commercial 
LDH activity assay kit (Sigma- Aldrich, Cat. No. MAK066 Sigma- Aldrich, 
Budapest, Hungary) according to the manufacturer's instructions.
3  | RESULTS
3.1 | CH4 concentrations
The background CH4 concentration in the airspace of the incuba-
tion chambers was 1.46.104 ± 94.95 ppm, and a rapid two or-
ders of increase (to 1.5.106 ± 58.12 ppm) was detected after the 
start of persufflation with a 2.2% CH4- artificial air mixture. This 
concentration was steadily maintained during the 2 hours re-
oxygenation period (Figure 1A,B). The dissolved CH4 concentra-
tion was 1.46.106 ± 76 381 ppm in the cell culture medium and 
1.41.106 ± 61 314 ppm in the MiRo 5 respiration medium 5 minutes 
following CH4 persufflation (Figure 1C,D).
3.2 | Effect of CH4 on the mitochondrial 
functions of the neonatal rat cardiomyocytes 
(NRMCs)
The coupling control protocol provides an opportunity to analyse the 
leak respiration of the mitochondria. As a result, significantly lower 
F I G U R E  1   CH4 concentrations measured by photoacoustic spectroscopy (PAS). A, The CH4 concentration in the airspace of the 
incubator (white column: baseline/background concentration; grey column: concentration under the persufflation with a 2.2% CH4– 
artificial air mixture). B, Representative record of CH4 measurement in the airspace of the incubator. C, The change in the dissolved CH4 
concentration of the cell culture medium under the persufflation with the 2.2% CH4– artificial air mixture. D, The CH4 concentration of the 
medium shown in a narrower range. Data are presented as means ± SEM. #P < .05 vs. baseline/background CH4 concentration (one- way 
ANOVA, Tukey's test)
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OxPhos was measured in the sI/R group in comparison with the nor-
moxia group (19.17 ± 9.37 pmol/s*mL vs. 50.51 ± 12.87 pmol/s*mL; 
P < .001) (Figure 2A). CH4 treatment in the sI/R + CH4 group sig-
nificantly enhanced oxygen consumption (to 40.88 ± 15.08 pmol/
s*mL; P = .004) (Figure 2A). The leak respiration decreased during 
sI/R (13.54 ± 2.66 pmol/s*mL; P < .001); however, it was amelio-
rated as a result of CH4 administration in the sI/R + CH4 group 
(19.94 ± 3.15 pmol/s*mL; P < .001) (Figure 2A). The sI/R significantly 
lowered the maximum respiratory capacity in comparison with the 
normoxia group (17.35 ± 4.46 pmol/s*mL vs. 35.72 ± 6.55 pmol/
s*mL; P < .001) (Figure 2A). CH4 treatment had no effect on the 
maximum respiratory capacity during sI/R (18.41 ± 2.99 pmol/s*mL; 
P = .986) (Figure 2A). Flux values in different states were corrected 
for ROX (data not shown). There was a significant rise in mitochon-
drial H2O2 levels in the I/R group as compared to the normoxia group. 
Incubation with CH4 during reoxygenation lowered the amount of 
H2O2 production (Figure 2B). The free radical leak was increased in 
the sI/R group; however, this rise was ameliorated as a result of CH4 
administration in the sI/R + CH4 group (8.74 ± 3.85 vs. 4.09 ± 1.57; 
P < .05) (Figure 2B). The CH4 incubation had no effect on the free 
radical leak in the normoxia + CH4 group compared with the nor-
moxia group (3.97 ± 2.80 vs. 2.91 ± 0.64; P > .05) (Figure 2B).
3.3 | Apoptosis, cytochrome c oxidase activity and 
viability of NRMCs
Neonatal rat cardiac myocytes were marked with TUNEL/DAPI stain-
ing to examine the presence of apoptosis. As expected, few TUNEL- 
positive cells were observed in the normoxia and normoxia + CH4 
groups (26 ± 9% and 26.3 ± 12% of cells, respectively; P = 1.00) 
(Figure 3A– B,E). sI/R was accompanied by an increased TUNEL posi-
tivity (sI/R: 52.4 ± 12% of cells) (Figure 3C,E), which was diminished 
as a result of CH4 incubation (sI/R + CH4: 20.1 ± 16.4 of cells; P = .01) 
(Figure 3D,E). The mitochondrial cytochrome c oxidase activity was 
determined with a spectrophotometric analysis. Remodelling the 
mitochondrial membrane during I/R results in cytochrome c release 
to the cytosol; therefore, this event can be considered an indicator 
of mitochondrial membrane damage. In the normoxia + CH4 group, 
the enzyme activity did not change in response to CH4 incubation 
F I G U R E  2   The effect of CH4 incubation on the neonatal rat cardiomyocytes (NRMCs). A, The oxygen consumption of the NRMCs 
(pmol/s/mL−1). The upper left- hand chart demonstrates representative records of mitochondrial oxygen consumption measured by HRR. The 
upper right- hand chart shows the oxidative phosphorylation (OxPhos), the lower left- hand chart presents the oligomycin leak (Omy), and 
the lower right- hand chart displays the maximum respiratory capacity (FCCP). B, Hydrogen peroxide (H2O2) production of the NRMCs. The 
upper chart represents the mitochondrial H2O2 production of the NRMCs in pmol/s/mg protein. The lower chart shows the free radical leak 
expressed as the percentage of oxygen consumption diverted by the H2O2 production in State 3. sI/R: simulated ischemia/reperfusion; CH4: 
methane; Dig + Succ + D: 1 μL digitonin + 10 mmol/L succinate + 5 mmol/L ADP; Omy: 0.5 μmol/L oligomycin; FCCP: 1 μmol/L carbonyl 
cyanide p- trifluoro- methoxyphenyl hydrazine; Rot: 1 μmol/L rotenone; Ama: 1 μmol/L antimycin- A; OxPhos: oxidative phosphorylation; 
ROX: residual oxygen consumption; white columns: normoxia group; grey columns: normoxia + CH4 group; red columns: sI/R group; black 
columns: sI/R + CH4 group. Data are presented as means ± SEM. *P < .05 vs. normoxia; #P < .05 vs. sI/R (one- way ANOVA, Tukey's test)
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as compared to the normoxia group (0.39 ± 0.17 vs. 0.37 ± 0.24; 
P = .992) (Figure 3F). In contrast, sI/R was accompanied by increased 
cytochrome c oxidase activity (1.43 ± 0.13; P < .001) (Figure 3F), 
which was diminished as a result of CH4 incubation (0.48 ± 0.15; 
P < .001) (Figure 3F).
Cardiomyocyte viability was determined with a calcein- based 
viability assay (Figure 4A). During the measurements, calcein 
passed through the cell membrane and hydrolysed to green fluo-
rescent calcein because of the endogenous esterases in the living 
cells. Compared with the normoxia group, the CH4 treatment led to 
a small drop in viability in the normoxia+CH4 group (93.48 ± 14.32 
vs. 83.89 ± 12.91; P = .891) (Figure 4B). Because of sI/R, the num-
ber of living cells decreased, a change shown by the significantly 
reduced calcein fluorescent intensity (61.74 ± 9.76; P = .041). Cell 
death because of sI/R was prevented with the CH4 treatment in 
the sI/R + CH4 group (86.63 ± 12.03; P = .003) (Figure 4B).
In the case of the LDH activity assay, there was no difference 
in this parameter between the two normoxic groups (0.22 ± 0.12 
F I G U R E  3   Cell apoptosis and cytochrome c oxidase activity. A, Normoxia group. B, Normoxia+CH4 group. C, sI/R group. D, 
sI/R + CH4 group. E, The number of apoptotic cells (%). F, Cytochrome c oxidase activity (%). White column: normoxia group; grey column: 
normoxia + CH4 group; red column: sI/R group; black column: sI/R + CH4 group. Data are presented as means ± SEM. *P < .05 vs. normoxia; 
#P < .05 vs. sI/R (one- way ANOVA, Tukey's test)
A B E
FC D
F I G U R E  4   Cell viability of the NRMCs. A, Representative image of calcein assay of cell viability. B, The number of living cells. C, Lactate 
dehydrogenase (LDH) enzyme activity. White column: normoxia group; grey column: normoxia + CH4 group; red column: sI/R group; black 
column: sI/R + CH4 group. Data are presented as means ± SEM. *P < .05 vs. normoxia; #P < .05 vs. sI/R (one- way ANOVA, Tukey's test)
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vs. 0.35 ± 0.11; P = .15) (Figure 4C). The LDH concentration was 
significantly lower in the sI/R + CH4 group than in the sI/R group 
(0.42 ± 0.10 vs. 0.68 ± 0.12; P = .041) (Figure 4C).
3.4 | Effects of CH4 on isolated cardiac 
mitochondria
Changes to mitochondrial membrane potential have been charac-
terized by means of the potential- sensitive fluorophore safranin. 
Substrates of respiratory complexes induced a significant hyper-
polarization in the mitochondrial membrane under normoxic condi-
tions (Figure 5A). In contrast, hyperpolarization was eliminated in 
the AR group. Substrate- induced changes in membrane potential 
were partially preserved by CH4 supplementation (Figure 5A). CH4 
applied during the anoxic period lowered the amount of H2O2 pro-
duction in leak states (Figure 5B). In terms of oxygen consumption, 
we investigated complex I and succinate- semialdehyde dehydro-
genase (complex II)- linked respiration separately. CH4 significantly 
decreased the oxygen consumption of complex I, whereas it had no 
effect on complex II- linked respiration under normoxic conditions. 
In contrast, CH4 treatment in the sI/R + CH4 group significantly im-
proved the oxygen consumption of complex II compared with com-
plex I (Figure 5B).
4  | DISCUSSION
Our primary aim was to outline a possible mechanism linked to the in 
vivo biological efficacy of CH4. The expected mitochondrial effects 
of CH4 have been characterized by HRR, and we have shown that 
the administration of CH4 reduces the sI/R- related mitochondrial 
ETC disturbance and mitigates subsequent apoptotic consequences. 
Of importance, CH4 preserved mitochondrial membrane potential 
(a marker of the integrity of the inner mitochondrial membrane) and 
decreased cytochrome c release (a sign of the integrity of the outer 
mitochondrial membrane) as well.
According to current knowledge, CH4 is not involved in catabolic or 
metabolic biochemical processes in the eukaryotic cell. Interestingly, 
in a pre- clinical model of myocardial infarction, CH4 treatment signifi-
cantly improved the cardiac function and reduced the apoptosis of 
cardiomyocytes.4 The anti- apoptotic and anti- oxidative effects of CH4 
have been demonstrated in other I/R settings as well.3– 5 These data 
all suggest that the underlying mechanism of action is intimately con-
nected with the mitochondrial functions.
Excessive oxidative stress is a major component of sI/R, and 
the mitochondrial ETC is a dominant source of ROS generation. 
Likewise, the majority of superoxide production is linked to complex 
I early in reperfusion.13– 16 This notion has been supported by stud-
ies showing that ischaemic preconditioning or pre- treatment with 
F I G U R E  5   The effect of CH4 on isolated cardiac mitochondria. The upper left- hand chart demonstrates representative records of 
mitochondrial membrane potential measured fluorimetrically by HRR. The continuous black line indicates changes in membrane potential; 
in parallel, the red line signifies the substrate- fuelled respiration. The upper right- hand chart presents changes in membrane potential in the 
experimental groups. The A/R group is labelled with a red line, the A/R + CH4 group with a black line, and the normoxia and normoxia + CH4 
groups with pale and dark grey lines, respectively. The lower left- hand chart shows complex I and II- driven mitochondrial oxygen 
consumption. The lower right- hand chart demonstrates H2O2 production in the case of reverse electron transfer (RET)
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reversible complex I inhibitors can limit ROS generation and cardiac 
IR injury.14,16 In this primary mitochondrial model of cardiac IR injury, 
we investigated mitochondrial coupling states with HRR. We tracked 
mitochondrial ROS production with HRR by using the fluorescent 
dye Amplex Red, and, in parallel, the mitochondrial membrane po-
tential was measured using the potential- sensitive fluorescence dye 
safranin. The respiratory activity of complex I remained stunned in 
the reoxygenation phase in line with the overwhelming ROS pro-
duction. In the presence of CH4, the complex I- linked respiration 
decreased in both control and simulated ischaemia- damaged mito-
chondria, but there were no changes in the presence of rotenone, 
an irreversible complex I inhibitor. This suggests that CH4 treatment 
reduced ROS generation via a partial blockade of electron transport 
in complex I. It should be added that two sites for superoxide pro-
duction have recently been explored on respiratory complex I, the 
ubiquinone (Q)- binding and flavin sites.15 The superoxide produc-
tion at the flavin site is linked to the forward electron transport, and 
its rate depends on the reduction state of the matrix nicotinamide 
adenine dinucleotide (NAD) pool. More importantly, the Q- binding 
site produces superoxide at much higher rates than the flavin site, 
driven by the reverse electron transport (RET) from complex II into 
complex I during reoxygenation.17 In isolated cardiac mitochondria, 
the underlying mechanism of RET is the accumulation of succinate 
during hypoxia and its subsequent rapid oxidation at reoxygenation 
in the presence of a high membrane potential.18 Rotenone, an ir-
reversible inhibitor of electron transport at the Q- binding site has 
been demonstrated to exert cardioprotection by decreasing RET in 
the early phase of reperfusion.14 Based on our results, the active site 
of CH4 is, as in the case of rotenone, distal to the flavin site, because 
it enhances mitochondrial ROS generation when the electrons enter 
complex I from NADH, but it inhibits ROS generation by RET from 
complex II. Large membrane potential is a prerequisite to drive the 
electrons against the gradient of redox potentials from complex II 
into complex I. It has been demonstrated in isolated mitochondria 
that only a 5% reduction in mitochondrial membrane potential will 
reduce peroxide production by 95%.19 Any manipulation of the 
RET pathway could potentially influence the end outcome of ROS 
production, even by lowering the driving hyperpolarization of the 
mitochondrial membrane potential. In our system, the addition of 
normoxic CH4 slightly decreased the substrate- induced hyperpolar-
ization in control mitochondria, in contrast to the preservative effect 
seen in the case of the anoxia- damaged membrane.
Next, the role of complex I and complex II in the post- anoxic 
cardiac mitochondrial respiration was addressed in more detail. 
As a result of CH4 treatment, respiration was inhibited when glu-
tamate + malate was used as a complex I substrate but not with 
succinate as a complex II substrate. This finding suggested that the 
addition of CH4 resulted in a decreased electron flux through com-
plex I but did not alter the succinate oxidation through complex II. 
Based on these findings, the drop in net ROS production from mito-
chondria with preserved succinate oxidation in the presence of CH4 
is most likely directly related to the inhibition of complex I. However, 
CH4 appears to provide a blockade of electron transport in complex 
I in contrast to a complete blockade of oxidative metabolism during 
reoxygenation.
Mitochondrial complex I has two conformations with different 
catalytic activities: an active state (A) and a deactivated state (D), 
which are present in A/D equilibrium at a ratio of 9:7 under physi-
ological conditions.20 The A/D transition occurs during ischaemia/
anoxia as an intrinsic mechanism, which produces a rapid response 
of the mitochondrial ETC to oxygen deprivation.21 Modulating fac-
tors of the A/D transition include the availability of oxygen, the re-
duced NAD pool in the matrix, the temperature and the pH. The 
physiological role of the accumulation of the D- form in anoxia is 
most probably to protect mitochondria from ROS generation be-
cause of the rapid burst of respiration following reoxygenation.13,22 
The transient preservation of complex I in the D- form was imple-
mented as a successful strategy against reperfusion injury in the 
post- ischaemic brain and heart.13,23,24 Though the entire NAD pool 
is reduced under ischaemic/anoxic conditions, the nucleotide at 
the flavin site could be rapidly decreased by the RET directly from 
ubiquinol at the beginning of reoxygenation. However, the D- form 
of the enzyme is unable to catalyse the RET, and therefore, de- 
activation may act as a protective valve by preventing reduction in 
the enzyme from downstream. Both the D- form of complex I and the 
rotenone- inhibited enzyme have restricted access to the quinone- 
binding pocket near the iron- sulphur cluster.25 The functional out-
come of this is, on the one hand, similar to the blockade of forward 
electron transfer within the A- form by a molecule of rotenone- like 
inhibitor bound at the quinone site. On the other hand, the RET oc-
curring in the D- form of the enzyme can also be restricted because 
of ubiquinol onto the iron- sulphur cluster, thereby eliminating the 
ROS formation.21,26 (Figure 6).
In this study, CH4 treatment restricted the forward electron 
transfer within complex I in control mitochondria whereas effec-
tively restricting RET in post- anoxic mitochondria. It can be con-
cluded that besides other mitochondrial sites, interactions with 
complex I certainly occupies a key position in the protective mech-
anism of CH4 treatment against sI/R injury. It is likely that this 
action includes conformational changes in respiratory complex I 
rather than direct interaction with a membrane- associated binding 
site. Earlier notions about the molecular mechanism by which CH4 
exerts a non- specific action were linked to the physical properties 
of the molecule. Hydrocarbon gases may modulate the structure 
and function of biological membranes, which has been demon-
strated in lipid bilayer models in vitro 27,28 and in animal models in 
vivo.29,30 As the smallest hydrocarbon molecule, CH4 may interact 
with the cell membrane, leading to haemolysis in erythrocytes in 
a concentration- dependent manner.27 In our study, a non- specific 
action of CH4 was demonstrated by increased OxPhos capacity 
and ameliorated leak respiration in the sI/R + CH4 group, linked 
to the preserved membrane integrity and electron transfer capac-
ity of mitochondria. It should be added that further, targeted in 
vitro studies may reveal further insights (eg on the involvement 
of ATP synthase), but this was beyond the scope of the current 
protocol. Conformational changes ranging from localized motions 
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of side chains to global structural changes are required for small 
molecules, even gases, to gain access to their target binding 
site.31 Therefore, research on this patient has shifted significantly 
towards the interaction of gases and proteins with membrane- 
mediated conformational change. Typical examples include an-
aesthetic gases, which have previously been known to exert their 
effect through the disruption of the membrane, yet accumulate 
and bind to multiple modulation sites of cellular membrane- 
embedded ion channels. Isoflurane and barbiturates have been 
identified to partition first in the lipid membrane and then bind 
to the transmembrane domain of the nicotinic acetylcholine re-
ceptor.32,33 In line with this, halothane has shown demonstrable 
effects on acetylcholine- activated ion channel kinetics through its 
conformational changes.34
5  | CONCLUSION
We have presented our first data on the effects of CH4 on tran-
sient anoxia- induced respiratory changes in cardiomyocyte cultures. 
Evidence suggests that CH4 treatment decreases myocyte injury 
through reduced ROS generation via blockade of electron transport 
in complex I and improved inner mitochondrial membrane integrity. 
Further in vivo studies are needed to investigate whether the ad-
ministration of CH4 would provide a way to attenuate the potentially 
harmful mitochondrial consequences of hypoxia- reoxygenation 
insults.
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